Oruka Therapeutics (ORKA) Free Cash Flow (QoQ) (2010 - 2026)
Oruka Therapeutics (ORKA) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Oruka Therapeutics | 965.06 Mn | 133.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.31% |
| Dec 31, 2025 | -4.56% |
| Sep 30, 2025 | 6.45% |
| Jun 30, 2025 | -11.00% |
| Mar 31, 2025 | -10.97% |
| Dec 31, 2024 | 32.35% |
| Sep 30, 2024 | -152.13% |
| Jun 30, 2024 | -6,467.26% |
| Mar 31, 2024 | 84.09% |
| Dec 31, 2023 | 36.73% |
| Sep 30, 2023 | -140.49% |
| Jun 30, 2023 | 56.49% |
| Mar 31, 2023 | -6.90% |
| Dec 31, 2022 | 40.27% |
| Sep 30, 2022 | 4.73% |
| Jun 30, 2022 | 39.02% |
| Mar 31, 2022 | 13.08% |
| Dec 31, 2021 | -1.62% |
| Sep 30, 2021 | -30.79% |
| Jun 30, 2021 | 28.85% |